Last year, University personnel established the high-performance computing system Virginia Assuring Controls Compliance of Research Data to aid institutions across the Commonwealth with their research efforts. The grant, funded by the National Science Foundation, was recently expanded to ACCORD-COVID, which serves institutions around the nation.
University researchers discovered that exercise prior to the development of macular degeneration caused a decrease in blood vessel overgrowth in laboratory mice. This correlates to macular degeneration in humans, meaning exercise could help prevent future vision loss.
With a limited number of people allowed in a laboratory at any given time, the Department of Environmental Sciences looks to alternatives, like outdoor field trips near Clark Hall or virtual bench labs.
The team hopes this website will help scientists, as well as the broader research community, find and use accurate information about the virus.
Since early June, biomedical graduate students have been allowed back to labs in shifts. Yet many labs are only working at partial capacity as access is determined by the square footage of their lab spaces in an effort to follow social-distancing rules.
Volunteers with TeleHealth Access for Seniors gather devices family, friends, businesses and schools no longer use and donate them to local hospitals and clinics for distribution to senior citizens.
Virginia ranked second throughout the U.S. for emergency public health preparedness.
Furukawa’s robot is equipped with UV lamps to sweep all surfaces of the room and camera with the necessary software to build a 3D map of the room.
TraceX will alert users if they were in contact with an individual who was symptomatic.
COVID-19 has added a layer of complexity to forming an immediate healthcare response when treating strokes as research has identified a link between COVID-19 infection and strokes.
Anthony Haro, executive director of TJACH, stated that at its peak activity, COVID-19 was estimated to infect nearly 40 percent of the homeless — currently 160 in number in Charlottesville.
The trial is expected to test whether or not fluvoxamine can prevent cytokine storms in patients with COVID-19, which could help keep the immune system in check and help fight the virus without destroying organs.
No matter the timelines or outcomes of COVID-19 research, scientists say the important thing to take home is that this is not going to be the last pandemic, and we will need to apply current research to other ones in the future.
Although the post-COVID-19 future is still nebulous, more physicians and patients are becoming comfortable with digital interactions, especially if it saves on travel time and expenses.
With the lottery system in place and more shipments from the federal government to come, around 650 Virginians hospitalized with COVID-19 will be able to take remdesivir.
For 131 years, The Cavalier Daily has served as the first draft of history for the University of Virginia and Charlottesville communities.
As an independent, non-profit student newsroom that receives no money from the University, we rely on contributions from readers like you. Join us in our mission of providing local news and creating opportunities for the next generation of journalists.
